Relvar Ellipta: new once-daily steroid/LABA inhaler

Relvar Ellipta is a new inhaled steroid/long-acting beta-agonist combination taken once daily. In our New products review, Steve Chaplin presents the data relating to its efficacy and adverse events, and Professor Neil Thomson discusses its place in therapy.

Relvar Ellipta new once daily steroid LABA inhaler

Add yours ↓
Web design and marketing agency Leamington Spa